According to an American study, cells collected at the time of Covid-19 diagnosis can predict whether patients will go on to develop severe or mild forms of the disease.
Researchers from the Broad Institute at MIT and Harvard, and the Ragon Institute at Massachusetts General Hospital, studied samples of such cells.
